Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Sponsor: Sirius Therapeutics Co., Ltd.
Summary
The study is a Phase 2a, randomized, double-blind, placebo-controlled, sequential cohort study to evaluate the pharmacodynamics (PD), safety and pharmacokinetics (PK) of multiple doses of SRSD107 in participants with coronary arterial disease (CAD) and/or peripheral arterial disease (PAD) with aspirin as background concomitant therapy.
Official title: A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of Subcutaneously Administered SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
104
Start Date
2026-01
Completion Date
2028-12
Last Updated
2026-01-05
Healthy Volunteers
No
Interventions
SRSD107
Administered S.C.
0.9 % sodium chloride
Administered S.C.